STX16
protein-codingsyntaxin 16, the group of Syntaxins
Gene summary
This gene encodes a protein that is a member of the syntaxin or t-SNARE (target-SNAP receptor) family. These proteins are found on cell membranes and serve as the targets for V-SNARES (vesicle-SNAP receptors) permitting specific synaptic vesicle docking and fusion. A microdeletion in the region of chromosome 20 where this gene is located has been associated with pseudohypoparathyroidism type Ib. Multiple transcript variants have been found for this gene. Read-through transcription also exists between this gene and the neighboring downstream aminopeptidase-like 1 (NPEPL1) gene. [provided by RefSeq, Mar 2011]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~28.3 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AD
Disease ID:MONDO:0011301
Submitter: Orphanet
Inheritance Pattern: AD
Disease ID:MONDO:0011301
Submitter: Ambry Genetics
Inheritance Pattern: AD
Disease ID:MONDO:0011301
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AD
Disease ID:MONDO:0011301
Submitter: PanelApp Australia
Clinical Genomic Database (CGD)
Manifestation: Endocrine; Renal
Intervention: Endocrine; Renal
Rationale: Complications such as osteitis fibrosa cystica may be effectively treated with calcium and vitamin D therapy
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to STX16 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_001001433.3. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 5 | 24 | 3 | 32 | ||
| missense | 95 | 11 | 1 | 107 | ||
| nonsense | 1 | 1 | ||||
| start loss | 1 | 1 | ||||
| frameshift | 5 | 5 | ||||
| splice donor/acceptor (+/-2bp) | 3 | 1 | 4 | |||
| Total | 3 | 0 | 107 | 35 | 5 | 150 |
Highest pathogenic variant AF is 0.0000027477283
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_001001433.1 | 9 | MANE Select | |
| Ensembl | ENSP00000360183.4 | 9 | MANE Select | |
| RefSeq | NP_001128244.1 | 8 | Standard | |
| RefSeq | NP_001128245.1 | 9 | Standard |
Model Organisms & Knockout Phenotypes
Observed phenotypic effects in mouse and zebrafish models
| Gene / Model | Organism | Observed Phenotype |
|---|---|---|
| stx16 | Danio rerio | Structure: whole organism Quality: increased curvature abnormal |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- SNARE interactions in vesicular transport - Homo sapiens (human)
- Nicotine Pathway (Dopaminergic Neuron), Pharmacodynamics
- Ectoderm Differentiation
- Vesicle-mediated transport
- Membrane Trafficking
Biological Process
- intracellular protein transport
- vesicle fusion
- retrograde transport, endosome to Golgi
- vesicle docking
- Golgi ribbon formation
Molecular Function
- SNARE binding
- SNAP receptor activity
- protein binding
- syntaxin binding
Cellular Component
- Golgi membrane
- cytoplasm
- Golgi apparatus
- trans-Golgi network
- cytosol
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000371141
- Coding exons
- 9
- Length
- 28255
- Individuals with no LoFs
- 125738
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 10
- Defined
- 125748
- p
- 0.0000398
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 0.952 | 160 | 198 | 0.809 | 0.0000115 | 2126 |
| Missense (PolyPhen) | 35 | 46.14 | 0.75855 | 540 | ||
| Synonymous | 0.435 | 70 | 74.8 | 0.936 | 0.00000435 | 627 |
| Loss of Function | 3.19 | 4 | 19.0 | 0.210 | 0.00000102 | 208 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.00012 | 0.00012 | rare |
| Latino/Admixed American | 0 | 0.0 | absent |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0.00011 | 0.00011 | rare |
| Finnish | 0 | 0.0 | absent |
| European (Non-Finnish) | 0.000026 | 0.000026 | rare |
| South Asian | 0.000098 | 0.000098 | rare |
| Other | 0 | 0.0 | absent |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: SNARE involved in vesicular transport from the late endosomes to the trans-Golgi network. {ECO:0000269|PubMed:18195106}.;
Recessive Scores
- pRec
- 0.0823
Intolerance Scores
- LoFtool
- 0.632
- RVIS EVS
- -0.25
- RVIS percentile EVS
- 35.99
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- E
- Indispensability score
- 0.863
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |